Advertisement

Topics

Assessment of the Utility of Fentanyl Matrix in Cancer Patients With Inadequately Controlled Pain by Non-opioids

2014-08-27 03:16:15 | BioPortfolio

Summary

The purpose of this study is to find out patient satisfaction with the treatment with fentanyl matrix and utility of fentanyl matrix in patients with pain inadequately controlled by non-opioids. Many researches have published findings about treating pain with transdermal fentanyl in patients who had been using strong opioids, but there is no domestic research to assess the treatment with fentanyl matrix for the purpose of controlling inadequately controlled pain by non-opioids.

Description

This study is open-label, single-arm, multicenter, prospective study to find out subject satisfaction with treatment with fentanyl matrix and the utility of fentanyl matrix in aspects of pain control in cancer patients with pain inadequately controlled pain by non-opioids. Patient satisfaction with pain treatment is the primary endpoint of this study and secondary endpoints are followings: Difference in pain intensity pre- and post-administration of study drug for 28 days; detailed reasons for patient satisfaction; dose of fentanyl matrix, times daily and dose of rescue analgesic, Investigator's overall evaluation on the pain treatment, change in Korean Cancer Pain Assessment Tool (KCPAT) pre- and post-administration of fentanyl matrix. Accurate assessment of pain is the most important factor in treating cancer pain. However, cancer pain assessment is so difficult because the assessment is very subjective itself, is complicated and has a strong psychological side. The interest in cancer pain treatment is on an increasing trend in Korea. In 2003, Korean Cancer Pain Assessment Tool (K-CPAT) was developed as a reflection of such interest and since then, its reliability, validity and utility were tested. starting with 12mcg/h of fentanyl matrix, the dose will be adjusted every 3 days depending on the patient's pain control (single-arm)

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Conditions

Pain

Intervention

fentanyl matrix

Status

Completed

Source

Janssen Korea, Ltd., Korea

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-08-27T03:16:15-0400

Clinical Trials [1231 Associated Clinical Trials listed on BioPortfolio]

Fentanyl Matrix in Lung Cancer Pain

The purpose of this study is to evaluate the usefulness of fentanyl matrix by assessing patients' satisfaction when administrating fentanyl matrix, a background pain treatment, and a break...

Study on Impact of Fentanyl Matrix on Improvement of Pain and Functioning in Spinal Disorder-related Pain

The purpose of this observational study is to investigate the impact of fentanyl matrix on improvement of pain and functioning in spinal disorder-related chronic pain.

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Non-Malignant Pain

The purpose of this study is to evaluate the safety of the matrix fentanyl patch ZR-02-01 in providing relief of non-malignant chronic pain.

Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -

The purpose of this study is to verify the effectiveness, safety and pharmacokinetics of fentanyl transdermal matrix patches containing either 12.5 mcg/hr, 25 mcg/hr, or 50 mcg/hr in Japan...

Gabapentin Versus Transdermal Fentanyl Matrix for Chronic Neuropathic Pain

Gabapentin is a first line medication and fentanyl is second line medication in neuropathic pain. But, there is no head to head study on the efficacy of those medication in neuropathic pai...

PubMed Articles [7234 Associated PubMed Articles listed on BioPortfolio]

DARK Classics in Chemical Neuroscience: Fentanyl.

Fentanyl rose to prominence as an alternative analgesic to morphine nearly 50 years ago; today, fentanyl has re-emerged as a dangerous recreational substance. The increased potency and analgesic effec...

Influence of aprepitant and localization of the patch on fentanyl exposure in patients with cancer using transdermal fentanyl.

The cutaneous fentanyl patch is widely used to treat continuous pain in patients with cancer. Its use is hampered by a high inter- and intrapatient pharmacokinetic variability. Factors that influence ...

Intravenous Low-Dose Ketamine Provides Greater Pain Control Compared to Fentanyl in a Civilian Prehospital Trauma System: A Propensity Matched Analysis.

A few studies report comparable analgesic efficacy between low-dose ketamine and opioids such as morphine or fentanyl; however, limited research has explored the safety and effectiveness of intravenou...

Analgesic effects of systemic fentanyl on cancer pain are mediated by not only central but also peripheral opioid receptors in mice.

Fentanyl is an opioid commonly prescribed for cancer pain. Using melanoma-bearing mice, we investigated whether peripheral action would contribute to fentanyl analgesia in cancer pain. Intravenous inj...

Abuse of fentanyl: An emerging problem to face.

Fentanyl is a potent synthetic opioid used as a narcotic analgesic supplement in general and regional anesthesia as well as in management of persistent, severe chronic pain. Alarming epidemiological a...

Medical and Biotech [MESH] Definitions

A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)

A secreted matrix metalloproteinase that is the predominant proteolytic activity in the enamel matrix. The enzyme has a high specificity for dental enamel matrix protein AMELOGENIN.

A transmembrane domain-containing matrix metalloproteinase. It is synthesized as an inactive zymogen that is activated by the proteolytic action of PROPROTEIN CONVERTASES. Matrix metalloproteinase 16 plays a direct role in the cleavage of proteins in the pericellular environment. In addition it can function indirectly by enzymatically activating the proprotein form of other MATRIX METALLOPROTEINASES such as the zymogen of MATRIX METALLOPROTEINASE 2.

A secreted matrix metalloproteinase that is believed to play a role in EXTRACELLULAR MATRIX remodeling and cell fate determination during normal and pathological processes. Matrix metalloproteinase 11 was originally isolated in primary BREAST NEOPLASMS and may be involved in the process of tumorigenesis.

A type of pain that is perceived in an area away from the site where the pain arises, such as facial pain caused by lesion of the VAGUS NERVE, or throat problem generating referred pain in the ear.

More From BioPortfolio on "Assessment of the Utility of Fentanyl Matrix in Cancer Patients With Inadequately Controlled Pain by Non-opioids"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Anesthesiology
An anesthesiologist (US English) or anaesthetist (British English) is a physician trained in anesthesia and perioperative medicine. Anesthesiologists are physicians who provide medical care to patients in a wide variety of (usually acute) situations. ...

Pain
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...


Searches Linking to this Trial